# Impact of the COVID‐19 Pandemic on Cochlear Implant Usage in Children

## TL;DR

The study found that the use of cochlear implants in children dropped significantly during the early years of the COVID-19 pandemic.

## Contribution

This study quantifies the decline in cochlear implant usage in children during the pandemic compared to prepandemic levels.

## Key findings

- HHP decreased from 55.0% in 2019 to 26.2% in 2020 during the pandemic.
- The decline in HHP during the late pandemic period (2022-2023) remained significant after controlling for confounders.
- The early pandemic period's HHP decline was no longer significant after adjusting for confounders.

## Abstract

To evaluate the impact of the COVID‐19 pandemic on cochlear implant (CI) usage in children by comparing hearing hour percentage (HHP) during the pandemic to prepandemic levels.

Retrospective Cohort Study.

Primary Children's Hospital, Utah.

A retrospective chart review was conducted for children aged 9 months to 18.9 years old who underwent CI between January 2018 and September 2023. Inclusion criteria comprised first‐time CI recipients with at least 1 year of follow‐up data. HHP was calculated by dividing total wear time by the expected daily awake time based on the patient's age. Multivariate linear regression analysis was performed to control for confounding variables of HHP, with demographic, clinical, and procedural variables entered as independent variables.

A total of 156 patients were included. A significant decline in HHP was observed during the pandemic, from 55.0% (SE = 4.3, n = 30) in 2019 to 26.2% (SE = 5.5, n = 22) in 2020. Regression analyses also revealed a significant decrease in HHP during both the early pandemic period (2020‐2021) (P = .0014) and late in the pandemic period (2022‐2023) (P = .011) compared to pre‐pandemic levels. After controlling for confounders, the late pandemic period remained significantly associated with a reduction in HHP (β = −15.6, P = .018), but the decline in HHP during the early phase of the pandemic was no longer significant.

Pandemic‐related disruptions led to a decline in pediatric CI use, underscoring the need for targeted support during public health crises.